The turnover of basic pharmaceutical products in Germany has shown variability from 2013 to 2023, with significant fluctuations such as the sharp decline in 2018 and periods of recovery thereafter. In 2023, the turnover stood at 1.4 Billion Euros. Over the last two years, the year-on-year variation has been minimal, with a slight increase of 0.22% in 2023. The CAGR over the last five years indicates a modest growth of 5.76% per year, despite volatility earlier in the decade.

The forecast for the upcoming five years indicates a stable turnover, hovering around 1.4 to 1.41 Billion Euros, suggesting negligible growth with a projected five-year CAGR of 0.09%. This steady outlook implies minimal fluctuations and a growth rate of approximately 0.43% over the period.

Expect ongoing stabilization in market turnover with very minimal change.
Monitor potential impacts from regulatory changes or advancements in pharmaceutical technology.
Keep an eye on global economic conditions which could influence pharmaceutical demand and pricing.